This Week at FDA: FDA postpones VRBPAC, QSR on the horizon, and Califf’s upcoming vote
This Week at FDAMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy